Đang chuẩn bị liên kết để tải về tài liệu:
MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Trastuzumab resistance is almost inevitable in the management of human epidermal growth factor receptor (HER) 2 positive breast cancer, in which phosphatase and tensin homolog deleted from chromosome 10 (PTEN) loss is implicated. |